United Bank (Virginia)’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,200
Closed -$662K 140
2018
Q4
$662K Buy
+2,200
New +$702K 0.14% 78
2018
Q2
Sell
-1,327
Closed -$363K 126
2018
Q1
$363K Hold
1,327
0.08% 93
2017
Q4
$423K Buy
1,327
+36
+3% +$11.5K 0.1% 91
2017
Q3
$404K Hold
1,291
0.39% 36
2017
Q2
$350K Hold
1,291
0.34% 39
2017
Q1
$353K Hold
1,291
0.36% 38
2016
Q4
$366K Sell
1,291
-164
-11% -$48.6K 0.44% 39
2016
Q3
$455K Hold
1,455
0.49% 41
2016
Q2
$352K Buy
1,455
+176
+14% +$46.4K 0.35% 44
2016
Q1
$333K Hold
1,279
0.33% 45
2015
Q4
$392K Hold
1,279
0.47% 39
2015
Q3
$373K Buy
+1,279
New +$422K 0.51% 39

Other funds holding BIIB

United Bank (Virginia)'s BIIB Position: Q1 2019 in Review

United Bank (Virginia) sold out of Biogen (BIIB) in Q1 2019, closing a stake of 2,200 shares — an estimated $662K sold.

United Bank (Virginia) first reported a position in BIIB in Q3 2015 and held it in 12 quarters. The position peaked at $662K in Q4 2018. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • United Bank (Virginia) reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • United Bank (Virginia) sold 2,200 Biogen shares in Q1 2019, an estimated $662K.
  • United Bank (Virginia) first reported a position in Biogen in Q3 2015 and held it in 12 quarters.
  • United Bank (Virginia)'s Biogen position peaked at $662K in Q4 2018.
  • 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on United Bank (Virginia)'s 13F filing for Q1 2019, filed 16 May 2019.